Medicare Enrolled

Dr. April Armstrong, MD

Clinical & Laboratory Dermatological Immunology Physician · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
200 UCLA MEDICAL PLZ STE 450, Los Angeles, CA 90095
3108256911
In practice since 2007 (19 years)
NPI: 1356477087 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Armstrong from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Armstrong? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Armstrong

Dr. April Armstrong is a clinical & laboratory dermatological immunology physician in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Armstrong performed 193 Medicare services across 102 unique beneficiaries.

Between the years covered by Open Payments, Dr. Armstrong received a total of $1,998,563 from 42 pharmaceutical and/or device companies across 1291 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in clinical & laboratory dermatological immunology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Armstrong is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 193 Medicare services $1,998,563 industry payments

Medicare Practice Summary

Medicare Utilization ↗
193
Medicare services
0.1× state median for clinical & laboratory dermatological immunology physician
102
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~10 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
83 $6 $42
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
76 $102 $575
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
21 $46 $390
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
13 $140 $898
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,998,563
Total received (2018-2024)
Avg $285,509/year across 7 years
Top 0% in CA for clinical & laboratory dermatological immunology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
1,291
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,530,500 (76.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$464,291 (23.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,772 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$404,466
2023
$351,615
2022
$320,166
2021
$303,566
2020
$198,049
2019
$200,786
2018
$219,914

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$69,722
ABBVIE INC.
$57,042
UCB, Inc.
$45,258
GENZYME CORPORATION
$43,200
Lilly USA, LLC
$36,729
Eli Lilly and Company
$31,378
Janssen Biotech, Inc.
$26,801
LEO Pharma AS
$16,273
Dermavant Sciences, Inc.
$13,332
Takeda Pharmaceuticals U.S.A., Inc.
$11,906
Ortho Dermatologics, a division of Bausch Health US, LLC
$8,750
Novartis Pharmaceuticals Corporation
$8,705
UCB SA
$8,349
Amgen Inc.
$6,946
LEO Pharma Inc.
$6,572
Galderma Laboratories, L.P.
$4,834
GlaxoSmithKline, LLC.
$3,200
Janssen Scientific Affairs, LLC
$1,800
Regeneron Pharmaceuticals, Inc.
$1,233
Boehringer Ingelheim International GmbH
$1,080
Regeneron Healthcare Solutions, Inc.
$504
Arcutis Biotherapeutics, Inc.
$414
Verrica Pharmaceuticals Inc.
$150
PFIZER INC.
$99
Incyte Corporation
$79
SUN PHARMACEUTICAL INDUSTRIES INC.
$46
Janssen Global Services, LLC
$43
Janssen Research & Development, LLC
$19
Top 3 companies account for 42.5% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$270,291
GENZYME CORPORATION
$183,841
Lilly USA, LLC
$172,229
AbbVie Inc.
$147,941
Eli Lilly and Company
$120,567
UCB, Inc.
$118,497
ABBVIE INC.
$109,847
LEO Pharma Inc.
$100,933
Novartis Pharmaceuticals Corporation
$86,753
Janssen Biotech, Inc.
$85,514
Janssen Scientific Affairs, LLC
$76,491
LEO Pharma AS
$54,695
NOVARTIS PHARMACEUTICALS CORPORATION
$48,818
Boehringer Ingelheim International GmbH
$47,461
Dermavant Sciences, Inc.
$40,715
Janssen Global Services, LLC
$39,161
UCB SA
$37,944
Regeneron Healthcare Solutions, Inc.
$34,298
Novartis Pharma AG
$28,422
Ortho Dermatologics, a division of Bausch Health US, LLC
$26,448
AbbVie, Inc.
$25,074
Boehringer Ingelheim Pharmaceuticals, Inc.
$23,650
PFIZER INC.
$20,700
Amgen Inc.
$14,109
Takeda Pharmaceuticals U.S.A., Inc.
$11,906
SANOFI-AVENTIS U.S. LLC
$10,554
Incyte Corporation
$8,829
EPI Health, LLC
$8,000
SUN PHARMACEUTICAL INDUSTRIES INC.
$5,846
Sun Pharmaceutical Industries Inc.
$5,298
Janssen Research & Development, LLC
$5,297
Galderma Laboratories, L.P.
$4,870
Mindera Corp
$4,225
DERMIRA, INC.
$3,500
Arcutis Biotherapeutics, Inc.
$3,216
GlaxoSmithKline, LLC.
$3,200
Organon LLC
$3,000
Galderma Research & Development, LLC
$2,370
Regeneron Pharmaceuticals, Inc.
$2,091
Almirall LLC
$1,600
Verrica Pharmaceuticals Inc.
$339
Celgene Corporation
$22
Top 3 companies account for 31.3% of all-time payments
Associated products mentioned in payments ›
ADBRY · AIN457A_COSENTYX_DERMATOLOGY · ALTRENO · Bimzelx · CIBINQO · COSENTYX · Cimzia · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EBGLYSS · ENSTILAR · Enbrel · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · INFLECTRA · Ilumya · Klisyri · OFEV · OLUMIANT · OPZELURA · ORENCIA · Otezla · PREVNAR 20 · QBREXZA · QGE031 · RINVOQ · SILIQ · SIMPONI ARIA · SKYRIZI · SPEVIGO · STELARA · Skyrizi · Sotyktu · TALTZ · TAPINAROF · TREMFYA · Tremfya · VTAMA · WYNZORA · XOLAIR · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (77%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for clinical & laboratory dermatological immunology physician in CA.

Looking for a clinical & laboratory dermatological immunology physician in Los Angeles?
Compare clinical & laboratory dermatological immunology physicians in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse clinical & laboratory dermatological immunology physicians nearby

Geographic Context

Clinical & laboratory dermatological immunology physicians within 10 mi
2
Per 100K population
0.0
County median income
$87,760
Nearest hospital
RONALD REAGAN UCLA MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Armstrong is a clinical cardiology specialist, with consulting-driven industry engagement in the top 0% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Armstrong experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Armstrong performed 83 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Armstrong receive payments from pharmaceutical companies?
Yes. Dr. Armstrong received a total of $1,998,563 from 42 companies across 1,291 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Armstrong's costs compare to other clinical & laboratory dermatological immunology physicians in Los Angeles?
Dr. Armstrong's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Armstrong) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →